HU0201834D0 - - Google Patents

Info

Publication number
HU0201834D0
HU0201834D0 HU0201834A HUP0201834A HU0201834D0 HU 0201834 D0 HU0201834 D0 HU 0201834D0 HU 0201834 A HU0201834 A HU 0201834A HU P0201834 A HUP0201834 A HU P0201834A HU 0201834 D0 HU0201834 D0 HU 0201834D0
Authority
HU
Hungary
Prior art keywords
hair loss
livestock
mammals
humans
compositions
Prior art date
Application number
HU0201834A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HU0201834D0 publication Critical patent/HU0201834D0/hu
Publication of HUP0201834A2 publication Critical patent/HUP0201834A2/hu
Publication of HUP0201834A3 publication Critical patent/HUP0201834A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU0201834A 2001-05-31 2002-05-30 Use of thyromimetic compounds for the manufacture of a pharmaceutical composition for the treatment of hair loss and such compositions HUP0201834A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29496201P 2001-05-31 2001-05-31

Publications (3)

Publication Number Publication Date
HU0201834D0 true HU0201834D0 (hu) 2002-08-28
HUP0201834A2 HUP0201834A2 (hu) 2003-01-28
HUP0201834A3 HUP0201834A3 (en) 2004-03-29

Family

ID=23135661

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201834A HUP0201834A3 (en) 2001-05-31 2002-05-30 Use of thyromimetic compounds for the manufacture of a pharmaceutical composition for the treatment of hair loss and such compositions

Country Status (19)

Country Link
US (2) US20030007941A1 (hu)
EP (1) EP1262177B1 (hu)
JP (1) JP4051230B2 (hu)
KR (1) KR100523503B1 (hu)
CN (1) CN1314393C (hu)
AT (1) ATE337009T1 (hu)
AU (1) AU784806B2 (hu)
CA (1) CA2387198C (hu)
CY (1) CY1105221T1 (hu)
DE (1) DE60214080T2 (hu)
DK (1) DK1262177T3 (hu)
ES (1) ES2267945T3 (hu)
HK (1) HK1049285B (hu)
HU (1) HUP0201834A3 (hu)
IL (2) IL188110A0 (hu)
PL (1) PL354216A1 (hu)
PT (1) PT1262177E (hu)
TW (1) TWI278313B (hu)
ZA (1) ZA200204189B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US7485298B2 (en) 2002-05-23 2009-02-03 Michael Powell Diagnosis and treatment of human dormancy-related sequellae
WO2003099105A2 (en) * 2002-05-23 2003-12-04 Powell Michael J Diagnosis and treatment of human dormancy syndrome
US7622103B1 (en) * 2003-03-27 2009-11-24 Cielo Jill M Hair and scalp toxin remover composition and method of its making
WO2006105109A2 (en) 2005-03-29 2006-10-05 The Trustees Of The University Of Pennsylvania Methods for generating new hair follicles, treating baldness, and hair removal
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
CN102459185B (zh) 2009-04-20 2015-06-03 田边三菱制药株式会社 新型甲状腺激素β受体激动剂
CA2819859A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
JP6156371B2 (ja) * 2012-06-08 2017-07-05 大正製薬株式会社 発毛組成物
PL2695611T3 (pl) 2012-08-06 2015-03-31 Dr August Wolff Gmbh & Co Kg Arzneimittel Eprotirom do stosowania w profilaktyce i/lub leczeniu zaburzeń włosów oraz jego kompozycje
US9827181B2 (en) 2013-06-05 2017-11-28 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
US9402876B2 (en) 2013-11-27 2016-08-02 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
CN104306168B (zh) * 2014-10-15 2017-05-24 华东师范大学 氮‑(4‑氯‑2,5‑二甲氧基苯基)‑5‑异丙基‑2‑甲氧基苯磺酰胺在促进毛发生长的应用
BR112019000706A8 (pt) 2016-07-15 2022-12-06 Pasteur Institut Agente de estímulo do receptor 1b de 5-hidroxitriptamina para reparo de pele e/ou cabelo
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
JP7360583B2 (ja) 2017-09-14 2023-10-13 国立研究開発法人理化学研究所 網膜組織の製造方法
CN108727344A (zh) * 2018-05-14 2018-11-02 嘉兴特科罗生物科技有限公司 一种化合物及其合成方法和应用
US11766392B2 (en) * 2018-10-05 2023-09-26 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
US11628132B2 (en) 2018-10-05 2023-04-18 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
CN113557311A (zh) 2019-03-13 2021-10-26 大日本住友制药株式会社 移植用神经视网膜的品质评价方法及移植用神经视网膜片
WO2020227549A1 (en) 2019-05-08 2020-11-12 Aligos Therapeutics, Inc. MODULATORS OF THR-β AND METHODS OF USE THEREOF
CN115244037A (zh) 2020-01-13 2022-10-25 上海诚益生物科技有限公司 作为甲状腺激素受体激动剂的被取代的三嗪酮类
EP4201927A1 (en) * 2020-08-19 2023-06-28 Chengdu Fanxi Biopharma Co., Ltd. Cyanotriazine derivative, preparation method therefor, and application thereof
CN116194079A (zh) 2020-09-11 2023-05-30 住友制药株式会社 用于移植用组织的介质
US20230313133A1 (en) 2020-09-11 2023-10-05 Riken Complex Containing Neural Retina-Containing Cell Aggregates and Matrix, and Method for Manufacturing Same
CN116327765A (zh) * 2023-03-27 2023-06-27 广州许愿树毛发医学科技有限公司 莲心碱类化合物作为β2-肾上腺素受体阻断剂的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU192989B (en) * 1983-08-17 1987-08-28 Wellcome Found Process for production of phisiologically active hormone preparatives
JPS61165311A (ja) * 1985-01-14 1986-07-26 Takeo Kinji 養毛化粧料
US5061798A (en) * 1985-01-18 1991-10-29 Smith Kline & French Laboratories, Ltd. Benzyl pyridyl and pyridazinyl compounds
US5284971A (en) * 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
WO1994023717A1 (en) * 1993-04-20 1994-10-27 The Procter & Gamble Company Methods of using hesperetin for sebum control and treatment of acne
TW382595B (en) * 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
US6255313B1 (en) * 1997-01-23 2001-07-03 Taisho Pharmaceutical Co., Ltd. Sustained release hair growth composition
NZ513449A (en) * 1999-03-01 2004-02-27 Pfizer Prod Inc Oxamic acids and derivatives as thyroid receptor ligands
CO5160290A1 (es) * 1999-03-29 2002-05-30 Novartis Ag Derivados de acido fenoxifeniloxamico sustituido .
JP2003500432A (ja) * 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター ジフェニルエーテル誘導体を用いて脱毛症を処置する方法
MXPA01012494A (es) * 1999-06-01 2002-07-02 Univ Texas Southwestern Med Ct Metodo para tratar perdida capilar con el uso de compuestos sulfonil tiromimeticos.
AR018700A1 (es) * 1999-06-01 2001-11-28 Procter & Gamble Compuesto, composicion y metodo para el tratamiento de la perdida del cabello
WO2000073292A1 (en) * 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Biaryl compounds
CA2375822A1 (en) * 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Substituted biaryl ether compounds
DK1088819T3 (da) * 1999-09-30 2005-09-12 Pfizer Prod Inc 6-azauracilderivater som thyroidreceptorligander
CA2403806A1 (en) * 2000-03-23 2002-09-20 Bayer Aktiengesellschaft Indoles for treating diseases that can be treated using thyroid hormones
AU2002223626A1 (en) * 2000-10-20 2002-04-29 Novartis Ag Combinations of a thyromimetic compound and a statin

Also Published As

Publication number Publication date
CA2387198C (en) 2007-02-13
EP1262177A2 (en) 2002-12-04
DE60214080T2 (de) 2007-01-04
DE60214080D1 (de) 2006-10-05
EP1262177A3 (en) 2003-09-03
ES2267945T3 (es) 2007-03-16
KR100523503B1 (ko) 2005-10-26
PT1262177E (pt) 2006-12-29
JP4051230B2 (ja) 2008-02-20
US20030007941A1 (en) 2003-01-09
CA2387198A1 (en) 2002-11-30
PL354216A1 (en) 2002-12-02
IL149843A0 (en) 2002-11-10
CY1105221T1 (el) 2010-03-03
CN1389203A (zh) 2003-01-08
EP1262177B1 (en) 2006-08-23
ATE337009T1 (de) 2006-09-15
IL188110A0 (en) 2008-03-20
DK1262177T3 (da) 2006-11-20
US20080125433A1 (en) 2008-05-29
AU784806B2 (en) 2006-06-29
HK1049285A1 (en) 2003-05-09
CN1314393C (zh) 2007-05-09
ZA200204189B (en) 2003-11-27
HUP0201834A3 (en) 2004-03-29
HK1049285B (zh) 2007-08-24
HUP0201834A2 (hu) 2003-01-28
KR20020092247A (ko) 2002-12-11
TWI278313B (en) 2007-04-11
IL149843A (en) 2008-11-26
AU4446202A (en) 2002-12-05
JP2002370978A (ja) 2002-12-24

Similar Documents

Publication Publication Date Title
HU0201834D0 (hu)
HK1145692A1 (zh) 人血管生成素- 的特異結合劑
BR0211251B1 (pt) composição para o tratamento de cabelo e/ou couro cabeludo.
BR0003184A (pt) Métodos para tratamento de pigmentação da pele
BR0209511B1 (pt) composiÇço herbicida sinergÍstica, e, mÉtodo para controlar vegetaÇço indesejÁvel.
IL142900A0 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
BR0202519B1 (pt) métodos para tratamento de material de madeira e para tratamento microbicida de material de madeira.
ATE325789T1 (de) Aminocyclohexylether-verbindungen und deren verwendung
DE60236318D1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
ATE355104T1 (de) Haarbehandlungsmittel
HUP0303261A3 (en) Carbamate compounds for use in preventing or treating bipolar disorder
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
MY136518A (en) Use of triazine trione sulphones for controlling coccidioses
GB9806029D0 (en) 8a-Azalides as veterinary antimicrobial agents
AU2003249999A8 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
ZA200307471B (en) Carbamate compounds for use in preventing or treating bipolar disorder.
DE60229502D1 (de) Verfahren und mittel zur behandlung von krebs bei hunden
RU97112967A (ru) Имплантант для пушных зверей
RU2001101227A (ru) Антибактериальное средство для лечения кожных заболеваний
ZA200103603B (en) Treatment of animal hides.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees